Literature DB >> 9050991

The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor.

G Tortora1, V Damiano, C Bianco, G Baldassarre, A R Bianco, L Lanfrancone, P G Pelicci, F Ciardiello.   

Abstract

Functional interactions between protein kinase A (PKA) and epidermal growth factor receptor (EGF-R) signalling pathways have been suggested. Unlike the type II isoform of PKA (PKAII), the type I (PKAI) and/or its regulatory subunit RIalpha are generally overexpressed in cancer cells and are induced following transforming growth factor alpha (TGF alpha)/EGF-R-dependent transformation. Downregulation of RIalpha/PKAI inhibits TGF alpha expression and EGF-R-dependent signalling. We have previously shown that addition of EGF to quiescent human normal epithelial MCF-10A cells determines PKAI expression and cell membrane translocation before cells enter S phase, while PKAI inhibition prevents S phase entry. Constitutive overexpression of PKAI confers the ability to grow in serum free medium, bypassing EGF requirement. Here we demonstrate a direct interaction of PKAI, but not of PKAII, with the activated EGF-R, that occurs within 5 min following EGF treatment of MCF-10A cells. Moreover, induction of mitogen-activated protein kinase (MAPK) activity following EGF-R activation is mimicked by PKAI overexpression and inhibited by downregulators of PKAI. Finally, the PKAI-EGF-R association occurs through the binding of RIalpha to the SH3 domain(s) of Grb2 adaptor protein, thus allowing the recruitment of the PKAI holoenzyme to the activated EGF-R. This is the first demonstration of a direct interaction of PKAI with the activated EGF-R macromolecular signalling complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050991     DOI: 10.1038/sj.onc.1200906

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Muscle-regulated expression and determinants for neuromuscular junctional localization of the mouse RIalpha regulatory subunit of cAMP-dependent protein kinase.

Authors:  S Barradeau; T Imaizumi-Scherrer; M C Weiss; D M Faust
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Protein kinase A-independent responses to beta-adrenoceptor agonists.

Authors:  G Dent
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.

Authors:  L A Cass; S A Summers; G V Prendergast; J M Backer; M J Birnbaum; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase.

Authors:  Deepti Chaturvedi; Helen M Poppleton; Teresa Stringfield; Ann Barbier; Tarun B Patel
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

5.  Involvement of protein kinase A in fibroblast growth factor-2-activated transcription.

Authors:  J P Pursiheimo; M Jalkanen; K Taskén; P Jaakkola
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Structural characterization of the membrane-associated regulatory subunit of type I cAMP-dependent protein kinase by mass spectrometry: identification of Ser81 as the in vivo phosphorylation site of RIalpha.

Authors:  K M Boeshans; K A Resing; J B Hunt; N G Ahn; J B Shabb
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

7.  Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.

Authors:  G Tortora; R Caputo; V Damiano; R Bianco; S Pepe; A R Bianco; Z Jiang; S Agrawal; F Ciardiello
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

8.  Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.

Authors:  Joshua N Honeyman; Elana P Simon; Nicolas Robine; Rachel Chiaroni-Clarke; David G Darcy; Irene Isabel P Lim; Caroline E Gleason; Jennifer M Murphy; Brad R Rosenberg; Lydia Teegan; Constantin N Takacs; Sergio Botero; Rachel Belote; Soren Germer; Anne-Katrin Emde; Vladimir Vacic; Umesh Bhanot; Michael P LaQuaglia; Sanford M Simon
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

9.  Phosphatidic acid induces ligand-independent epidermal growth factor receptor endocytic traffic through PDE4 activation.

Authors:  Andrés Norambuena; Claudia Metz; Juan E Jung; Antonia Silva; Carolina Otero; Jorge Cancino; Claudio Retamal; Juan C Valenzuela; Andrea Soza; Alfonso González
Journal:  Mol Biol Cell       Date:  2010-06-16       Impact factor: 4.138

10.  Epac, not PKA catalytic subunit, is required for 3T3-L1 preadipocyte differentiation.

Authors:  Zhenyu Ji; Fang C Mei; Xiaodong Cheng
Journal:  Front Biosci (Elite Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.